ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Sanofi-Aventis (Suisse) SA - Tetravac, suspension injectable
0061201
Tetravacsuspension injectable
J07CA02Diphtheria-Pertussis-Poliomyelitis-Tetanus
18.08.1999  
Composition
toxoidum diphtheriae 20 U.I., toxoidum tetani 40 U.I., bordetellae pertussis antigenum: toxoidum pertussis 25 µg et haemagglutininum filamentosum 25 µg, virus poliomyelitis typus 1 inactivatus 29 U., virus poliomyelitis typus 2 inactivatus 7 U., virus poliomyelitis typus 3 inactivatus 26 U., aluminium 0.3 mg ut aluminii hydroxidum hydricum ad adsorptionem, formaldehydum, medium 199 cum phenylalaninum 12.5 µg et kalium, ethanolum 2 mg, phenoxyethanolum, acidum aceticum glaciale q.s. ad pH, natrii hydroxidum q.s. ad pH, aqua ad iniectabile q.s. ad suspensionem pro 0.5 ml, residui: glutaralum, neomycinum, streptomycinum, polymyxinum B.
Packungsbestandteile
Injection suspension 
  
 
Active AgentDose
Toxoidum Diphtheriae20 UI
Toxoidum Tetani40 UI
BAG: Active AgentDose
Toxoidum Diphtheriae20 UI
Toxoidum Pertussis25 mcg
Toxoidum Tetani40 UI
Vaccinum Poliomyelitidis Inactivatum (Salk typ I, II, III)62 U
 
Inactive agentsDoseadditional_information
Acidum Aceticum Glaciale  
Alumine0.3 mg 
Cum Phenylalaninum12.5 µg 
Ethanol2 mg 
Formaldehydum  
Haemagglutininum Filamentosum25 µg 
Inactivatus26 U 
Potassium  
Medium199  
Phenoxyethanol  
Toxoidum Pertussis25 µgbordetellae pertussis antigenum
Virus Poliomyelitis Typus3  
 
Package numberPackage SizeEFPCPCategorySLOut of trade (MedRef)
003 20.2138.40BSLNo
2025 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home